Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
Titel:
Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
Auteur:
Ball, Brian J. Famulare, Christopher A. Stein, Eytan M. Tallman, Martin S. Derkach, Andriy Roshal, Mikhail Gill, Saar I. Manning, Benjamin M. Koprivnikar, Jamie McCloskey, James Testi, Rebecca Prebet, Thomas Al Ali, Najla H. Padron, Eric Sallman, David A. Komrokji, Rami S. Goldberg, Aaron D.